Intuitive Surgical (ISRG) and The Competition Head to Head Analysis
Intuitive Surgical (NASDAQ: ISRG) is one of 85 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its peers? We will compare Intuitive Surgical to similar companies based on the strength of its dividends, profitability, earnings, institutional ownership, risk, valuation and analyst recommendations.
Valuation and Earnings
This table compares Intuitive Surgical and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Intuitive Surgical||$2.70 billion||$735.90 million||50.52|
|Intuitive Surgical Competitors||$2.17 billion||$225.99 million||-11.38|
Intuitive Surgical has higher revenue and earnings than its peers. Intuitive Surgical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
Intuitive Surgical has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Intuitive Surgical’s peers have a beta of 1.51, indicating that their average stock price is 51% more volatile than the S&P 500.
Insider and Institutional Ownership
31.4% of Intuitive Surgical shares are held by institutional investors. Comparatively, 52.0% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 2.2% of Intuitive Surgical shares are held by insiders. Comparatively, 18.9% of shares of all “Advanced Medical Equipment & Technology” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
This table compares Intuitive Surgical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Intuitive Surgical Competitors||-293.22%||-31.89%||-10.28%|
This is a breakdown of current ratings for Intuitive Surgical and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Intuitive Surgical Competitors||267||1869||3359||108||2.59|
Intuitive Surgical presently has a consensus price target of $139.91, suggesting a potential downside of 64.22%. As a group, “Advanced Medical Equipment & Technology” companies have a potential upside of 3.59%. Given Intuitive Surgical’s peers higher probable upside, analysts plainly believe Intuitive Surgical has less favorable growth aspects than its peers.
Intuitive Surgical beats its peers on 8 of the 13 factors compared.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company’s instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.